A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-tomoderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial

iA_2021_20

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

iA_2021_20.pdf

https://air.repo.nii.ac.jp/record/5481/files/iA_2021_20.pdf

iA_2021_20

application/pdf

ファイル	ライセンス
iA_2021_20.pdf (453.3 kB) sha256 b989a8d93a4c03433611f0f96b9d611094b83222fd00de52f755d35b0ed0a239

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays